Monday, June 27, 2022
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Cancer

How blood cancers outsmart the immune system

February 21, 2018
in Cancer
0
Share on FacebookShare on Twitter

Researchers have discovered how some of the blood cancers known as myeloproliferative neoplasms (MPNs) evade the immune system. Their findings reveal that a subset of MPNs might be susceptible to treatment with immune checkpoint inhibitors that specifically target the PD-1/PD-L1 pathway (a signaling network that normally functions as an "off switch" that blocks T cells from attacking other cell types), such as the currently marketed therapies Keytruda™ and Tecentriq™. Certain cancers hijack the PD-1/PD-L1 pathway to prevent T cells from eradicating malignant cells, and scientists have remained uncertain if MPNs (a group of diseases where bone marrow makes too many red blood cells, white blood cells or platelets) avoided the immune system through similar mechanisms. Many patients with MPNs have abnormally activated versions of a signaling protein named JAK2, and Alessandro Prestipino et al. determined that the mutant molecule helps activate PD-L1 production – exposing a potentially promising therapeutic vulnerability. In a patient with the MPN polycythemia vera who had undergone a stem cell transplant and subsequently relapsed, treatment with an anti-PD-1 checkpoint inhibitor led to improved symptoms. Anti-PD-1 therapy was also effective in mice with MPNs. Interestingly, T cells from healthy donors growing in culture together with JAK2-mutant cells turned down gene expression for growth and energy production – a result consistent with the observation that mutant JAK2 drives immune cell exhaustion. Prestipino and colleagues further tracked down the specific proteins that partnered with mutant JAK2 to boost PD-L1. The authors speculate that cancer-driving mutations might cooperate with similar immune-escape mechanisms in other cancers.

###

Media Contact

Science Press Package
[email protected]
202-326-6440
@AAAS

http://www.aaas.org

http://dx.doi.org/10.1126/scitranslmed.aam7729

Share26Tweet16Share4ShareSendShare
  • Dr. Jung-Mo Ahn

    Scientists discover new molecule that kills hard-to-treat cancers

    91 shares
    Share 36 Tweet 23
  • Native American women, reproductive politics and forced sterilizations

    76 shares
    Share 30 Tweet 19
  • The Sussex researchers who used international collaboration and 3D printing to stem PPE shortages in Nigeria

    65 shares
    Share 26 Tweet 16
  • Ultra-thin film creates vivid 3D images with large field of view

    72 shares
    Share 29 Tweet 18
  • Repairing nature with DNA technology

    64 shares
    Share 26 Tweet 16
  • True lies: People who lie via telling truth viewed harshly, study finds

    64 shares
    Share 26 Tweet 16
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Action needed to reduce e-cigarette use among adolescents to lower lifetime CVD risk

Native American women, reproductive politics and forced sterilizations

Scientists discover new molecule that kills hard-to-treat cancers

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 189 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....